Tumour Microenvironment - Key Publications

 

 

Publications are listed according to year, with the most recent first. Within each year, publications are listed in alphabetical order, based on the first author’s surname. Click on “Publication link” to access the publication on PubMed. Use the search box above to find particular publications based on author or terms in the title.

———————————————————————————————————————————————————–

  • Regulatory T-cell directed therapies in liver diseases

    J Hepatol. 2013 Nov;59(5):1127-34.

    Oo YH, Sakaguchi S.

  • Autophagy: a cyto-protective mechanism which prevents primary human hepatocyte apoptosis during oxidative stress.

    Bhogal RH, Weston CJ, Curbishley SM, Adams DH, Afford SC.

    Autophagy. 2012 Apr;8(4):545-58.

  • Fibroblasts as therapeutic targets in rheumatoid arthritis and cancer.

    Juarez M, Filer A, Buckley CD.

    Swiss Med Wkly. 2012 Feb 24;142:w13529.

  • Are we ready to start studies of Th17 cell manipulation as a therapy for cancer?

    Middleton GW, Annels NE, Pandha HS.

    Cancer Immunol Immunother. 2012 Jan;61(1):1-7.

  • Interaction between invariant NKT cells and myeloid-derived suppressor cells in cancer patients: evidence and therapeutic opportunities.

    Mussai F, De Santo C, Cerundolo V.

    J Immunother. 2012 Jul;35(6):449-59.

  • Identification and angiogenic role of the novel tumor endothelial marker CLEC14A.

    Mura M, Swain RK, Zhuang X, Vorschmitt H, Reynolds G, Durant S, Beesley JF, Herbert JM, Sheldon H, Andre M, Sanderson S, Glen K, Luu NT, McGettrick HM, Antczak P, Falciani F, Nash GB, Nagy ZS, Bicknell R.

    Oncogene. 2012 Jan 19;31(3):293-305.